EMA issues advice on use of Lagevrio (molnupiravir) for the treatment of COVID-19
EMA’s human medicines committee (CHMP) has issued advice on the use of Lagevrio (also known as molnupiravir or MK 4482) for the treatment of COVID-19. The medicine, which is currently not authorised in the EU, can be used to treat adults with COVID-19 who do not require supplemental oxygen and who
Click to view: Daily Cyprus News Headlines - Live
Article automatically added to our system on Monday, November 22, 2021
Contents of this article including associated images are © PIO (Official) 2023
Views & opinions expressed are those of the author and/or PIO (Official) .
You may also like the following pages:
More from PIO (Official) | Latest News | Trending News | Local News | Weather | Webcams | Restaurants | Flights